RECENT NEWS

Digital pathology provider Proscia has been chosen by the Netherlands Cancer Institute (NKI), one of the top 10 comprehensive cancer centres in Europe, to deploy its Concentriq Dx platform. NKI is transitioning to Concentriq Dx to expand its digital pathology practice, laying the foundation for its pathologists to deliver personalised diagnoses that better inform treatment decisions.

Construction of a new Acute Hospital Laboratory (AHL) has begun at the Leeds General Infirmary (LGI). The 24/7 operated AHL is being created to provide urgent pathology facilities to support clinical teams at the LGI when the main pathology service relocates to the brand-new state-of-the-art pathology laboratory currently under construction at St James’s Hospital.

Hamamatsu Photonics has released a new digital slide scanner system, the NanoZoomer S20MD.

The latest POCT Innovators event, ‘POCT: The Power to Disrupt’ has been unveiled for Nottingham on 28 March.

Enalees, a biotech company producing rapid molecular diagnostic tests for the veterinary profession based on an isothermal amplification technique (LAMP PCR), today announces that it has appointed Eric Germain to the position of managing director.

ProtonDx, an in vitro diagnostic company designing, manufacturing and marketing rapid, accurate, multi‑pathogen, point‑of‑need diagnostic solutions, has announced a strategic partnership with commercial POCT provider Katalyst Laboratories, to distribute ProtonDx’s Dragonfly rapid in vitro diagnostic system.

A new whitepaper published by scientific instrumentation distributor SciMed explores how the laboratory industry can improve sustainability in ways that improve experimental output and save money.

Siemens Healthineers has announced the launch of a Centre of Excellence for Immunoassay Instrument Research and Development in Swords, Ireland. The new Centre will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders.

Thermo Fisher Scientific is to support a new collaborative laboratory and office space for growing biotech businesses in Florida as a founding sponsor. The firm says its involvement with Momentum Labs in Alachua, Florida is part of its efforts to support emerging biotechnology companies as they address key challenges in bringing new therapies to market.

Scientific Laboratory Supplies (SLS) has announced the acquisition of C&M Scientific, a Scotland-based distributor of laboratory equipment and service provider specialising in installation, validation, calibration, repair and ongoing maintenance for scientific equipment.

Isohelix, a UK-based specialist biological sample collection company, has begun the process to gain full regulatory approval of the GeneFix Saliva DNA Collectors from the US Food and Drug Administration (FDA).

Fujifilm Irvine Scientific has launched a new nutrient-based HEK293-specific feed medium, designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.

A major new report on in vitro diagnostics, ‘A Strategic Technology Roadmap’ has been launched, proposing a 10-year strategy to put the UK at the forefront of the industry.

US-based digital pathology and artificial intelligence (AI) firm Paige has announced a collaboration with Microsoft to apply the power of AI to digital pathology images to develop and deliver a new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care.

The North East Innovation Lab is celebrating a two-year milestone birthday and has expanded its work in accelerating the development of diagnostics for a range of virus and health threats.

Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to discover and develop next-generation cancer therapies.

Qiagen has announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.

The National Institutes of Health has awarded eight research grants in the USA, to refine new technologies for early diagnosis of severe illnesses resulting from SARS-CoV-2 infection in children.

European manufacturers of medical devices are set to get more time to prepare for forthcoming regulatory changes, after the European Commission adopted a proposal to delay the changes.

Perspectum, a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer, has completed the first close of its Series C funding round. The new $36 million investment was led by Oppenheimer Holdings. The Series C funding brings the total amount raised since inception to circa $120 million.